Education
About Us
Working with TipRanks
Follow Us
Cormedix (CRMD)
NASDAQ:CRMD
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.25Last Year’s EPS
-0.25Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 25, 2025
|% Change Since: -35.84%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
CorMedix reported a strong financial performance with record-breaking revenue and profitability in Q4 2024, driven by success in the outpatient segment and growth in the inpatient segment. However, challenges such as anticipated net price erosion, delayed LDO implementation, increased operating expenses, and slower progress with expanding the customer base present potential hurdles. Overall, the highlights of financial growth and strategic progress are significant, but the lowlights indicate some critical areas needing attention.Company Guidance
During the CorMedix Inc. earnings call, financial guidance for 2025 was detailed, highlighting a strong start with over $25 million in purchase orders for the first quarter. While full-year revenue guidance wasn't provided, expectations for net revenue from existing customers in the first half of 2025 were set between $50 million and $60 million, with over $33 million anticipated for the first quarter. The company projected a slight price erosion for DefenCath beginning in the second quarter. Operating expenses for 2025 were guided to be approximately $72 million to $78 million, driven by increased R&D spending. The call emphasized the company's focus on expanding its customer base and therapeutic indications for DefenCath, with inpatient sales expected to contribute significantly to revenue by the end of 2025.Record-Breaking Revenue and Growth
CorMedix reported net revenue of $31.2 million for Q4 2024 and $43.5 million for the full year, both exceeding Wall Street consensus. The fourth quarter was the first profitable commercial quarter in the company's history with a net income of $13.5 million and adjusted EBITDA of $15.3 million.
Strong Outpatient Segment Performance
The strong revenue and profit results were driven by uptake among patients at US Renal Care and implementation at midsized customers IRC and DCI, as well as utilization by other small outpatient dialysis customers.
Positive Financial Outlook
CorMedix started 2025 with over $25 million in purchase orders and estimates net revenue from existing purchasing customers for the first six months of 2025 to be in the range of $50 million to $60 million.
Inpatient Segment Growth
Utilization increased at larger hospitals. A new inpatient field team was formed, expected to be active in four to five weeks, with promotional activities already commenced at VA facilities.
Phase 3 Clinical Study and Expansion Efforts
CorMedix is beginning a Phase 3 clinical study for reducing CLABSIs in TPN patients. The company submitted an application for orphan drug status for this indication.
---
CRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 25, 2025 | $10.77 | $7.34 | -31.85% |
| Oct 30, 2024 | $12.97 | $10.05 | -22.51% |
| Aug 14, 2024 | $3.78 | $4.92 | +30.16% |
| May 09, 2024 | $5.70 | $5.41 | -5.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cormedix (CRMD) report earnings?
Cormedix (CRMD) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Cormedix (CRMD) earnings time?
Cormedix (CRMD) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CRMD EPS forecast?
CRMD EPS forecast for the fiscal quarter 2025 (Q1) is 0.25.
---